[Recommendation for the optimal use of bendamustine in Japan]

Rinsho Ketsueki. 2014 Mar;55(3):311-20.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bendamustine Hydrochloride
  • Clinical Trials as Topic
  • Cytomegalovirus Infections / complications
  • Drug Administration Schedule
  • Drug Eruptions / etiology
  • Evidence-Based Medicine
  • Hepatitis B / complications
  • Humans
  • Immunocompromised Host
  • Japan
  • Lymphoma, B-Cell / blood
  • Lymphoma, B-Cell / complications
  • Lymphoma, B-Cell / drug therapy*
  • Lymphoma, Mantle-Cell / blood
  • Lymphoma, Mantle-Cell / complications
  • Lymphoma, Mantle-Cell / drug therapy*
  • Nausea / chemically induced
  • Nitrogen Mustard Compounds / administration & dosage*
  • Nitrogen Mustard Compounds / adverse effects
  • Opportunistic Infections / complications
  • Rituximab
  • Vasculitis / etiology

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Nitrogen Mustard Compounds
  • Rituximab
  • Bendamustine Hydrochloride